Angel Invest Boston

Why angel-scale biotech is so promising: Learn More Qiuyan Xu, PhD is a statistician, an entrepreneur and a colleague at Walnut. We talked about the startups she has invested in, her immigrant journey and the work she does at Gravitate AI (https://www.gravitate.ai) Sponsors: Purdue University entrepreneurship & Peter Fasse, patent attorney at Fish & Richardson Highlights: Sal Daher Introduces Qiuyan Xu, PhD, Statistician, Entrepreneur and Angel Investor Qiuyan Xu Talks About Her Investment in AOA Diagnostics Qiuyan Xu Talks About Her Investment in Octagon Therapeutics What Sal Daher Looks for in an Academic Founder Qiuyan Xu Wonders About the Long Holds in Life Science Investments “It's an important thing to remember now that the early-stage, angel-scale life science investing is really, really just beginning to take off.” “There are some angels who have done very successfully, with just a handful of companies.” “Weeding out the obvious losers. I think it makes a lot of sense.” We Still Know Surpris